Amneal Pharmaceuticals, Inc. announced the launch of its authorized generic for Xyrem® (Sodium Oxybate) oral solution CIII in the United States. Sodium Oxybate oral solution,...
QOL Medical, LLC, a ground-breaking rare disease pharmaceutical company, announced it has selected Optum Frontier Therapies as its new pharmacy partner to support CSID...
